| Tretinoin | Approved Investigational Nutraceutical | MMRN1 | 22915 |
upregulated | Tretinoin results in increased expression of MMRN1 mRNA | 4q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MN1 | 4330 |
downregulated | Tretinoin results in decreased expression of MN1 mRNA | 22q12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MND1 | 84057 |
downregulated | Tretinoin results in decreased expression of MND1 mRNA | 4q31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MNDA | 4332 |
upregulated | Tretinoin results in increased expression of MNDA mRNA | 1q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MOB3B | 79817 |
downregulated | Tretinoin results in decreased expression of MOB3B mRNA | 9p21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MOK | 5891 |
downregulated | Tretinoin results in decreased expression of MOK mRNA | 14q32.31 | |
| Tretinoin | Approved Investigational Nutraceutical | MORC2 | 22880 |
downregulated | Tretinoin results in decreased expression of MORC2 mRNA | 22q12.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MORC4 | 79710 |
upregulated | Tretinoin results in increased expression of MORC4 mRNA | Xq22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MORN2 | 729967 |
downregulated | Tretinoin results in decreased expression of MORN2 mRNA | 2p22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MOXD1 | 26002 |
upregulated | Tretinoin results in increased expression of MOXD1 mRNA | 6q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MPDU1 | 9526 |
upregulated | Tretinoin results in increased expression of MPDU1 mRNA | 17p13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MPHOSPH9 | 10198 |
downregulated | Tretinoin results in decreased expression of MPHOSPH9 mRNA | 12q24.31 | |
| Tretinoin | Approved Investigational Nutraceutical | MPO | 4353 |
downregulated | Tretinoin results in decreased expression of MPO mRNA | 17q22 | |
| Tretinoin | Approved Investigational Nutraceutical | MPP1 | 4354 |
upregulated | Tretinoin results in increased expression of MPP1 mRNA | Xq28 | |
| Tretinoin | Approved Investigational Nutraceutical | MPP3 | 4356 |
downregulated | Tretinoin results in decreased expression of MPP3 mRNA | 17q21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | MPP4 | 58538 |
upregulated | Tretinoin results in increased expression of MPP4 mRNA | 2q33.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MPP6 | 51678 |
downregulated | Tretinoin results in decreased expression of MPP6 mRNA | 7p15.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MPPED2 | 744 |
upregulated | Tretinoin results in increased expression of MPPED2 mRNA | 11p14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MPZL2 | 10205 |
upregulated | Tretinoin results in increased expression of MPZL2 mRNA | 11q24 | |
| Tretinoin | Approved Investigational Nutraceutical | MRAP2 | 112609 |
downregulated | Tretinoin results in decreased expression of MRAP2 mRNA | 6q14.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MRC2 | 9902 |
downregulated | Tretinoin results in decreased expression of MRC2 mRNA | 17q23 | |
| Tretinoin | Approved Investigational Nutraceutical | MRNIP | 51149 |
upregulated | Tretinoin results in increased expression of MRNIP mRNA | 5q35.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MROH6 | 642475 |
downregulated | Tretinoin results in decreased expression of MROH6 mRNA | 8q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MRPL11 | 65003 |
downregulated | Tretinoin results in decreased expression of MRPL11 mRNA | 11q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MRPL15 | 29088 |
downregulated | Tretinoin results in decreased expression of MRPL15 mRNA | 8q11.23 | |